about
Biologic complexity in sickle cell disease: implications for developing targeted therapeuticsInformed consent in clinical research: Consensus recommendations for reform identified by an expert interview paneleTACTS: a method for dynamically filtering clinical trial search results.Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial.NIDA Clinical Trials Network Common Data Elements Initiative: Advancing Big-Data Addictive-Disorders Research.Re-Engineering Alzheimer Clinical Trials: Global Alzheimer's Platform NetworkAccelerating Digital Mental Health Research From Early Design and Creation to Successful Implementation and Sustainment.Examining Barriers and Practices to Recruitment and Retention in Stroke Clinical Trials.Expanding the National Drug Abuse Treatment Clinical Trials Network to address the management of substance use disorders in general medical settings.Patient registries for substance use disordersSubversive subjects: rule-breaking and deception in clinical trials.Cross-system evaluation of clinical trial search engines.A transformative subfield in rehabilitation science at the nexus of new technologies, aging, and disability.Recruitment and retention monitoring: facilitating the mission of the National Institute of Neurological Disorders and Stroke (NINDS)Electronic health records based phenotyping in next-generation clinical trials: a perspective from the NIH Health Care Systems Collaboratory.Challenges and opportunities for integrating preventive substance-use-care services in primary care through the Affordable Care Act.Varying ethics rules in clinical research and routine patient care--research ethics committee chairpersons' views in Finland.The life cycles of six multi-center adaptive clinical trials focused on neurological emergencies developed for the Advancing Regulatory Science initiative of the National Institutes of Health and US Food and Drug Administration: Case studies from thA pragmatic randomized trial comparing tablet computer informed consent to traditional paper-based methods for an osteoporosis study.Understanding practice-based research participation: The differing motivations of engaged vs. non-engaged clinicians in pragmatic clinical trials.Education and training of clinical and translational study investigators and research coordinators: A competency-based approachAdvancing Regulatory Science With Computational Modeling for Medical Devices at the FDA's Office of Science and Engineering LaboratoriesReady or not? Observations from a long-standing community engagement advisory board about investigator competencies for community-engaged research
P2860
Q21284789-FA159F0D-83A7-4CBD-A084-61F8EA595F63Q26801171-540D35D3-524B-4179-B582-4537C5B56DC9Q30558154-A0733AEB-D644-4BB5-A320-AC1ECC7AC6D8Q30620556-4D11B98B-BBB4-49A5-B74B-0C5F97B46187Q30912157-30CAD2AA-4BE6-48AF-9526-96401541DA18Q33613942-FE053697-4532-40F4-921A-1490DE75FE35Q33726215-A5C56E7D-98B9-46B6-A3C9-A50569A13E0BQ33926392-A4D72E46-0C56-4635-B470-587F11EDC9A4Q33968667-3B7F2F20-DD86-4CA9-8717-AC88C9EA8A20Q33968724-F3B444FE-41C6-4E56-8593-B774C6D1940EQ35085835-D909DB41-E75F-444E-8E5B-7E4F065F6301Q35569707-4EA597E7-E013-44C9-B37D-D6217AFC1A79Q36251243-FE64945F-E89F-4743-AC4E-41D07E16ED56Q36452730-CF476D28-700E-4F80-8757-7DA275EF5748Q37389452-91E364A0-CBED-443C-BA1A-6F2B5A7F2110Q37700093-7CD5826C-6F92-4AE9-A828-511723B1B9F9Q37704353-A19C30E0-C610-49E7-AEE5-B3D1D7181C93Q47132460-F63A48BB-B4AE-43A7-8C9D-C23D39924AA5Q55263250-B1130CF8-88CA-4505-BC4B-9A3907DD2A79Q55312450-F3BBD26C-D513-4D60-AAAE-B9FB835B2807Q56542888-4E43A723-FD37-499D-A56A-970F98D535A4Q57821480-8505A2E2-BEC3-4404-84D3-BA98B5D1807EQ58131236-49CCA229-929B-4DB9-8393-B425B01B8249
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
type
altLabel
Envisioning a Transformed Clinical Trials Enterprise in the United States
@en
P356
P1433
P1476
Envisioning a Transformed Clinical Trials Enterprise in the United States
@en
P356
10.17226/13345
P407
P577
2012-01-01T00:00:00Z